Global B-Cell Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 25 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.

This report studies the global B-Cell Non-Hodgkin's Lymphoma Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for B-Cell Non-Hodgkin's Lymphoma Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of B-Cell Non-Hodgkin's Lymphoma Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global B-Cell Non-Hodgkin's Lymphoma Drug total market, 2018-2029, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: B-Cell Non-Hodgkin's Lymphoma Drug total market, key domestic companies and share, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug revenue by player and market share 2018-2023, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global B-Cell Non-Hodgkin's Lymphoma Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma and Teva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World B-Cell Non-Hodgkin's Lymphoma Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global B-Cell Non-Hodgkin's Lymphoma Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global B-Cell Non-Hodgkin's Lymphoma Drug Market, Segmentation by Type
    Oral
    Injection

Global B-Cell Non-Hodgkin's Lymphoma Drug Market, Segmentation by Application
    Hospital
    Retail Pharmacy
    Other

Companies Profiled:
    Roche
    Gilead Sciences
    TG Therapeutics
    Bayer
    Secura Bio
    Epizyme
    Eisai
    Acrotech Biopharma
    Teva
    Eagle Pharmaceuticals
    MundiPharma

Key Questions Answered
1. How big is the global B-Cell Non-Hodgkin's Lymphoma Drug market?
2. What is the demand of the global B-Cell Non-Hodgkin's Lymphoma Drug market?
3. What is the year over year growth of the global B-Cell Non-Hodgkin's Lymphoma Drug market?
4. What is the total value of the global B-Cell Non-Hodgkin's Lymphoma Drug market?
5. Who are the major players in the global B-Cell Non-Hodgkin's Lymphoma Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 B-Cell Non-Hodgkin's Lymphoma Drug Introduction
    1.2 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World B-Cell Non-Hodgkin's Lymphoma Drug Total Market by Region (by Headquarter Location)
        1.3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
        1.3.3 China B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
        1.3.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
        1.3.5 Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
        1.3.6 South Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
        1.3.7 ASEAN B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
        1.3.8 India B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 B-Cell Non-Hodgkin's Lymphoma Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.2 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region
        2.2.1 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2018-2023)
        2.2.2 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Region (2024-2029)
    2.3 United States B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.4 China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.5 Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.6 Japan B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.7 South Korea B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.8 ASEAN B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)
    2.9 India B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029)

3 World B-Cell Non-Hodgkin's Lymphoma Drug Companies Competitive Analysis
    3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for B-Cell Non-Hodgkin's Lymphoma Drug in 2022
        3.2.3 Global Concentration Ratios (CR8) for B-Cell Non-Hodgkin's Lymphoma Drug in 2022
    3.3 B-Cell Non-Hodgkin's Lymphoma Drug Company Evaluation Quadrant
    3.4 B-Cell Non-Hodgkin's Lymphoma Drug Market: Overall Company Footprint Analysis
        3.4.1 B-Cell Non-Hodgkin's Lymphoma Drug Market: Region Footprint
        3.4.2 B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
        3.4.3 B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Comparison
        4.2.1 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based B-Cell Non-Hodgkin's Lymphoma Drug Companies and Market Share, 2018-2023
        4.3.1 United States Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2018-2023)
    4.4 China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Market Share, 2018-2023
        4.4.1 China Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2018-2023)
    4.5 Rest of World Based B-Cell Non-Hodgkin's Lymphoma Drug Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Injection
    5.3 Market Segment by Type
        5.3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2018-2023)
        5.3.2 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2024-2029)
        5.3.3 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2018-2023)
        6.3.2 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2024-2029)
        6.3.3 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.1.4 Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.2.4 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 TG Therapeutics
        7.3.1 TG Therapeutics Details
        7.3.2 TG Therapeutics Major Business
        7.3.3 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.3.4 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 TG Therapeutics Recent Developments/Updates
        7.3.6 TG Therapeutics Competitive Strengths & Weaknesses
    7.4 Bayer
        7.4.1 Bayer Details
        7.4.2 Bayer Major Business
        7.4.3 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.4.4 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Bayer Recent Developments/Updates
        7.4.6 Bayer Competitive Strengths & Weaknesses
    7.5 Secura Bio
        7.5.1 Secura Bio Details
        7.5.2 Secura Bio Major Business
        7.5.3 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.5.4 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Secura Bio Recent Developments/Updates
        7.5.6 Secura Bio Competitive Strengths & Weaknesses
    7.6 Epizyme
        7.6.1 Epizyme Details
        7.6.2 Epizyme Major Business
        7.6.3 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.6.4 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Epizyme Recent Developments/Updates
        7.6.6 Epizyme Competitive Strengths & Weaknesses
    7.7 Eisai
        7.7.1 Eisai Details
        7.7.2 Eisai Major Business
        7.7.3 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.7.4 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Eisai Recent Developments/Updates
        7.7.6 Eisai Competitive Strengths & Weaknesses
    7.8 Acrotech Biopharma
        7.8.1 Acrotech Biopharma Details
        7.8.2 Acrotech Biopharma Major Business
        7.8.3 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.8.4 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Acrotech Biopharma Recent Developments/Updates
        7.8.6 Acrotech Biopharma Competitive Strengths & Weaknesses
    7.9 Teva
        7.9.1 Teva Details
        7.9.2 Teva Major Business
        7.9.3 Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.9.4 Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Teva Recent Developments/Updates
        7.9.6 Teva Competitive Strengths & Weaknesses
    7.10 Eagle Pharmaceuticals
        7.10.1 Eagle Pharmaceuticals Details
        7.10.2 Eagle Pharmaceuticals Major Business
        7.10.3 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.10.4 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Eagle Pharmaceuticals Recent Developments/Updates
        7.10.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 MundiPharma
        7.11.1 MundiPharma Details
        7.11.2 MundiPharma Major Business
        7.11.3 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
        7.11.4 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 MundiPharma Recent Developments/Updates
        7.11.6 MundiPharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 B-Cell Non-Hodgkin's Lymphoma Drug Industry Chain
    8.2 B-Cell Non-Hodgkin's Lymphoma Drug Upstream Analysis
    8.3 B-Cell Non-Hodgkin's Lymphoma Drug Midstream Analysis
    8.4 B-Cell Non-Hodgkin's Lymphoma Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key B-Cell Non-Hodgkin's Lymphoma Drug Players in 2022
    Table 12. World B-Cell Non-Hodgkin's Lymphoma Drug Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global B-Cell Non-Hodgkin's Lymphoma Drug Company Evaluation Quadrant
    Table 14. Head Office of Key B-Cell Non-Hodgkin's Lymphoma Drug Player
    Table 15. B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
    Table 16. B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
    Table 17. B-Cell Non-Hodgkin's Lymphoma Drug Mergers & Acquisitions Activity
    Table 18. United States VS China B-Cell Non-Hodgkin's Lymphoma Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share (2018-2023)
    Table 23. China Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share (2018-2023)
    Table 26. Rest of World Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share (2018-2023)
    Table 29. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2018-2023) & (USD Million)
    Table 31. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2024-2029) & (USD Million)
    Table 32. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2018-2023) & (USD Million)
    Table 34. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2024-2029) & (USD Million)
    Table 35. Roche Basic Information, Area Served and Competitors
    Table 36. Roche Major Business
    Table 37. Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 38. Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Roche Recent Developments/Updates
    Table 40. Roche Competitive Strengths & Weaknesses
    Table 41. Gilead Sciences Basic Information, Area Served and Competitors
    Table 42. Gilead Sciences Major Business
    Table 43. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 44. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Gilead Sciences Recent Developments/Updates
    Table 46. Gilead Sciences Competitive Strengths & Weaknesses
    Table 47. TG Therapeutics Basic Information, Area Served and Competitors
    Table 48. TG Therapeutics Major Business
    Table 49. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 50. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. TG Therapeutics Recent Developments/Updates
    Table 52. TG Therapeutics Competitive Strengths & Weaknesses
    Table 53. Bayer Basic Information, Area Served and Competitors
    Table 54. Bayer Major Business
    Table 55. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 56. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Bayer Recent Developments/Updates
    Table 58. Bayer Competitive Strengths & Weaknesses
    Table 59. Secura Bio Basic Information, Area Served and Competitors
    Table 60. Secura Bio Major Business
    Table 61. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 62. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Secura Bio Recent Developments/Updates
    Table 64. Secura Bio Competitive Strengths & Weaknesses
    Table 65. Epizyme Basic Information, Area Served and Competitors
    Table 66. Epizyme Major Business
    Table 67. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 68. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Epizyme Recent Developments/Updates
    Table 70. Epizyme Competitive Strengths & Weaknesses
    Table 71. Eisai Basic Information, Area Served and Competitors
    Table 72. Eisai Major Business
    Table 73. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 74. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Eisai Recent Developments/Updates
    Table 76. Eisai Competitive Strengths & Weaknesses
    Table 77. Acrotech Biopharma Basic Information, Area Served and Competitors
    Table 78. Acrotech Biopharma Major Business
    Table 79. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 80. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Acrotech Biopharma Recent Developments/Updates
    Table 82. Acrotech Biopharma Competitive Strengths & Weaknesses
    Table 83. Teva Basic Information, Area Served and Competitors
    Table 84. Teva Major Business
    Table 85. Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 86. Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Teva Recent Developments/Updates
    Table 88. Teva Competitive Strengths & Weaknesses
    Table 89. Eagle Pharmaceuticals Basic Information, Area Served and Competitors
    Table 90. Eagle Pharmaceuticals Major Business
    Table 91. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 92. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Eagle Pharmaceuticals Recent Developments/Updates
    Table 94. MundiPharma Basic Information, Area Served and Competitors
    Table 95. MundiPharma Major Business
    Table 96. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
    Table 97. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug Upstream (Raw Materials)
    Table 99. B-Cell Non-Hodgkin's Lymphoma Drug Typical Customers
List of Figure
    Figure 1. B-Cell Non-Hodgkin's Lymphoma Drug Picture
    Figure 2. World B-Cell Non-Hodgkin's Lymphoma Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World B-Cell Non-Hodgkin's Lymphoma Drug Total Market Size (2018-2029) & (USD Million)
    Figure 4. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2018-2029) & (USD Million)
    Figure 13. B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 16. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 23. India B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of B-Cell Non-Hodgkin's Lymphoma Drug by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for B-Cell Non-Hodgkin's Lymphoma Drug Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for B-Cell Non-Hodgkin's Lymphoma Drug Markets in 2022
    Figure 27. United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type in 2022
    Figure 31. Oral
    Figure 32. Injection
    Figure 33. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2018-2029)
    Figure 34. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2022
    Figure 36. Hospital
    Figure 37. Retail Pharmacy
    Figure 38. Other
    Figure 39. B-Cell Non-Hodgkin's Lymphoma Drug Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global B-Cell Non-Hodgkin's Lymphoma Drug market size was valued at USD 8119.4 million in 2023 and is forecast to a readjusted size of USD 12940 million by 2030 with a CAGR of 6.9% during review period.

Global B-Cell Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2024-2030

Global B-Cell Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ 12940 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period (2024-2030).

Product Tags

B-Cell Non-Hodgkin's Lymphoma Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>